Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

4.660

-0.080 (-1.69%)

At close: Mar 20, 2026, 4:00 PM EDT

4.690

+0.030 (0.64%)

After-hours: Mar 20, 2026, 5:29 PM EDT

Niagen Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	64.29	27.33	20.44	28.22	16.7	18.81
Cash & Short-Term Investments	64.29	27.33	20.44	28.22	16.7	18.81
Cash Growth	130.55%	33.68%	-27.56%	69.01%	-11.24%	-16.82%
Accounts Receivable	8.51	5.23	8.48	5.23	2.69	2.18
Total Trade Receivables	8.51	5.23	8.48	5.23	2.69	2.18
Inventory	18.79	14.53	14.68	13.6	11.68	11.54
Other Current Assets	2.03	2.45	2.97	1.86	1.15	1
Total Current Assets	93.62	49.53	46.57	48.91	32.22	33.52
Net Property, Plant & Equipment	3.86	4.54	6.32	7.36	4.43	4.66
Other Intangible Assets	0.25	0.51	0.67	0.86	1.08	1.31
Other Long-Term Assets	0.42	0.38	0.5	0.72	0.63	0.76
Total Assets	98.14	54.96	54.06	57.84	38.36	40.25
Accounts Payable	12.74	10.23	9.68	10.42	9.45	9.63
Accrued Expenses	8.7	9.49	7.34	6.48	6.13	4.42
Current Portion of Leases	0.98	0.7	0.7	0.55	0.62	0.85
Unearned Revenue	0.29	0.2	0.16	0.16	0.28	0.17
Total Current Liabilities	22.71	20.62	17.87	17.61	16.48	15.06
Long-Term Leases	2.08	2.58	3.56	4.15	1.02	0.87
Other Long-Term Liabilities	2.67	3.31	3.96	4.35	4.44	3.87
Total Long-Term Liabilities	4.75	5.89	7.52	8.5	5.46	4.74
Total Liabilities	27.46	26.51	25.39	26.11	21.93	19.8
Common Stock	0.08	0.08	0.07	0.07	0.06	0.06
Additional Paid-in Capital	239.27	218.85	214.09	200.61	158.19	142.29
Accumulated Other Comprehensive Income	-0.01	-0	-0	-0	-0	-
Retained Earnings	-168.66	-190.46	-185.49	-168.95	-141.83	-121.9
Shareholders' Equity	70.68	28.46	28.67	31.73	16.42	20.45
Total Liabilities & Equity	98.14	54.96	54.06	57.84	38.36	40.25
Total Debt	3.06	3.28	4.26	4.7	1.64	1.72
Net Cash (Debt)	61.24	24.05	16.18	23.52	15.06	17.09
Net Cash Growth	154.64%	48.59%	-31.18%	56.16%	-11.89%	-21.70%
Net Cash Per Share	0.72	0.32	0.23	0.35	0.25	0.30
Book Value	70.68	28.46	28.67	31.73	16.42	20.45
Book Value Per Share	0.84	0.38	0.41	0.47	0.27	0.36
Tangible Book Value	70.43	27.95	28	30.87	15.34	19.13
Tangible Book Value Per Share	0.83	0.37	0.40	0.46	0.25	0.34

Updated Mar 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q